Logo

Sophia Genomics DDM for Blood Cancers

Jun 01, 2021

Sophia Genetics has introduced Sophia DDM for Blood Cancers, a suite of tools for analyzing next-generation sequencing of myeloid tumors. The collection includes Myeloid Solution, which targets 30 common myeloid cancer genes, Myeloid Solution Plus, which also analyzes 119 RNA fusion driver genes, and Extended Myeloid Solution, which covers 98 different genes. 

Breaking News
The Scan

Cancer Survival Linked to Mutational Burden in Pan-Cancer Analysis

A pan-cancer paper appearing in JCO Precision Oncology suggests tumor mutation patterns provide clues for predicting cancer survival that are independent of other prognostic factors.

Australian Survey Points to Public Support for Genetic Risk Disclosure in Relatives of At-Risk Individuals

A survey in the European Journal of Human Genetics suggests most adult Australians are in favor of finding out if a relative tests positive for a medically actionable genetic variant.

Study Links Evolution of Stony Coral Skeleton to Bicarbonate Transporter Gene

A PNAS paper focuses on a skeleton-related bicarbonate transporter gene introduced to stony coral ancestors by tandem duplication.

Hormone-Based Gene Therapy to Sterilize Domestic Cat

A new paper in Nature Communication suggests that gene therapy could be a safer alternative to spaying domestic cats.